Wuhan Coronavirus Resource Thread
Re: Wuhan Coronavirus Resource Thread
https://www.financialexpress.com/lifest ... t/2260652/
Why is Delhi govt only using covaxin in June?
Why is Delhi govt only using covaxin in June?
Re: Wuhan Coronavirus Resource Thread
Centre looks to finetuning vaccine strategy: studying single-shot effect to mixing doses https://indianexpress.com/article/india ... 7275/lite/
Single dose oxford is bad idea ^
Phe UK prospective study shows only 33% effectiveness w single dose Oxford against B617 (so called Indian) variant of Chinese virus
Single dose oxford is bad idea ^
Phe UK prospective study shows only 33% effectiveness w single dose Oxford against B617 (so called Indian) variant of Chinese virus
Re: Wuhan Coronavirus Resource Thread
#VaccineJihad
Dr Afreen Khan said in her defence that before she could inform the higher authorities, she only received a call from the chief medical officer (CMO) inquiring about the incident. She said she regrets that she did not inform the authorities about the incident.
According to reports, Dr Afreen was aware of this, but still, she did not bother to inform her superiors about Niha’s act. Reports had suggested that Dr Afreen Khan could be transferred from the Jamalpur Urban health centre to her original posting in Harduaganj.
https://www.opindia.com/2021/05/aligarh ... l-syringe/
--------------------------
All the bad expletive's possible should be reserved for this Gandhi/nehru/congress trash. It failed to do the house cleaning 70 years ago and poisonous snakes are breeding here even now..
Dr Afreen Khan said in her defence that before she could inform the higher authorities, she only received a call from the chief medical officer (CMO) inquiring about the incident. She said she regrets that she did not inform the authorities about the incident.
According to reports, Dr Afreen was aware of this, but still, she did not bother to inform her superiors about Niha’s act. Reports had suggested that Dr Afreen Khan could be transferred from the Jamalpur Urban health centre to her original posting in Harduaganj.
https://www.opindia.com/2021/05/aligarh ... l-syringe/
--------------------------
All the bad expletive's possible should be reserved for this Gandhi/nehru/congress trash. It failed to do the house cleaning 70 years ago and poisonous snakes are breeding here even now..
-
- BRFite -Trainee
- Posts: 89
- Joined: 02 Oct 2017 07:31
Re: Wuhan Coronavirus Resource Thread
Got vaccinated today in Fortis Gurgaon. It is like playing "fastest fingers first" on Cowin portal. However, the experience of vaccination itself is very straightforward and simplified. Took only 30 mins followed by 30 mins mandatory waiting time. People are observing social distance and token system helps avoid long queues. Hospital is strictly following the Cowin procedures and my identification was checked twice. Walk-in is being allowed for ppl needing second dose. From chatter with ppl waiting in queue, everyone wants to get Cowaxin. Covishield is second choice. Ppl are willing to wait more to get Cowaxin.
Re: Wuhan Coronavirus Resource Thread
The article has more than what is mentioned in the post. I will quote themIndraD wrote:Centre looks to finetuning vaccine strategy: studying single-shot effect to mixing doses https://indianexpress.com/article/india ... 7275/lite/
Single dose oxford is bad idea ^
Phe UK prospective study shows only 33% effectiveness w single dose Oxford against B617 (so called Indian) variant of Chinese virus
The Government plans to review the impact of its decision to extend the interval between Covishield doses once it collects data from a newly proposed Covid vaccine tracker platform that it will launch shortly, The Indian Express has learnt. The data, sources said, may also help the Government decide whether to approve a single-dose regimen for Covishield.
The data from the new platform is expected to be analysed around August, sources said.
Important to understandA platform is being established where three sets of administrative data in terms of diagnostic data, vaccine data and the overall disease data are to be harmonised. Based on that, we will look at vaccine effectiveness, reinfections and trends as vaccine coverage increases,” Dr N K Arora, chairman of the Covid working group under the National Technical Advisory Group on Immunisation (NTAGI), said.
why we need to stduy moreDiscussions on the need to study the effectiveness of Covid vaccines began in March-April, according to Arora. Before this, India had not been tracking the effectiveness of vaccines it was administering in a real-world situation.
This help the people who are vaccine skeptics or those who believe vaccines dont workThe idea is to study aspects like breakthrough infections following vaccinations and the severity of infections post-immunisation. “This will give an idea of how long you are likely to be protected from the disease after immunisation… It will also tell us the impact of increasing the interval between doses on vaccine efficacy and whether there is a need for modification either by increasing or decreasing the interval,” Arora said, adding that the data will be reviewed “two to three months later”.
Another aim of the review is to understand whether a single dose is effective, a source close to the development told The Indian Express on condition of anonymity. “An argument being placed is that other viral vector vaccines have single-dose versions, and this might work for Covishield too, which started out as a single-dose vaccine,” the source said.
IOW lot of aims along with single dose effectiveness.
Real practical situation in India and also the worldA single-dose regimen would help the Government cover the population faster with its vaccination drive, which has slowed down due to a shortage.
Good intergration of available platforms.The vaccine-tracking platform is expected to work using existing platforms developed by the Centre to track Covid cases and vaccinations. This includes the use of the RT-PCR and Aarogya Setu app, which has collected data on testing and confirmation of cases, and the CoWIN platform created to help people register, book and receive certificates for vaccinations.
“As new ideas come up, as the thinking process becomes sharper, and as a better understanding of the progression of the disease develops, such strategies become clearer and processes have been put into practice,” he said.
According to him, the effort is to make this a “permanent” platform that can be used for other new and emerging diseases that require vaccinations in the future.
great efforts This must be applauded.
Re: Wuhan Coronavirus Resource Thread
Hopefully, GoI introduces a centralized platform to track vaccinations and other related metadata.
Re: Wuhan Coronavirus Resource Thread
https://twitter.com/SuchitraElla/status ... 8400906246IndraD wrote:https://www.financialexpress.com/lifest ... t/2260652/
Why is Delhi govt only using covaxin in June?
From Suchitra Ella of Bharat Biotech whih manufactures coviaxin.
Re: Wuhan Coronavirus Resource Thread
even single dose is good enough but 2nd dose is the best- BMJ article
May 18 2021
May 18 2021
More than nine in 10 UK adults have antibodies to SARS-CoV-2 following one dose of the Oxford AstraZeneca or Pfizer BioNTech vaccine, while almost everyone does after a second dose, preliminary data suggest.1
A study of 8517 adults in England and Wales by University College London’s Virus Watch project found that 96.42% (95% confidence interval 96 to 96.79) of people who had either vaccine had developed antibodies 28 to 34 days after their first dose, rising to 99.08% (95% CI 97.8 to 99.62) within seven to 14 days of the second dose.
Seropositivity rates and spike antibody levels rose more quickly following the first dose of the Pfizer vaccine (89.27% (95% CI 83.52 to 93.25) than for AstraZeneca (66.27% (95% CI 2.56 to 69.80) at 14 to 20 days, but were equivalent for both vaccines by 4 weeks (96.17% (95% CI 94.22 to 97.50) v 95.21% (95% CI 93.75 to 96.35)). ( pfizer vaccines had faster antibody levels relatively only)
“Our data indicate very high rates of seroconversion to spike following a single dose of either vaccine, with near complete seroconversion following a second dose, in people with no evidence of prior infection,” said the UCL research team led by Maddie Shrotri.
(important data to know )Participants provided blood samples and self-reported vaccination status. None had antibodies before receiving a first dose.
IOW people with old age, chronic diseases and cancers with treatment had some issues. This is not unusual but expected.After a single dose, there was evidence to suggest a significant difference in antibody levels by age group at ≥28 days (P=0.0001), with levels lower in older people (18 to 34y, median 63.4 U/ml (IQR 34.2 to 99.34) v ≥80y, 26.13 (8.34 to 80.4) (P=0.0001)).
In 65 to 79 year olds who had had only one dose, lower antibody levels were observed in men (25.9 v 42.3 U/ml, P<0.0001), people with a chronic condition (33.0 v 41.2 U/ml, P<0.0001), diabetes (22.32 v 36.01 U/ml, P<0.0001), cardiovascular disease (32.1 v 36.7 U/ml, P=0.0002), or those history of cancer (30.1 v 35.7 U/ml, P=0.0001), particularly those with haematological rather than solid organ cancer (7.48 v 31.68 U/ml, P<0.0001), and those currently on immunosuppressive therapy (21.7 v 35.6 U/ml, P<0.0001).
But disparities did not persist after a second dose, with high antibody titres (≥250U/ml) observed for nearly all people across all ages, demographics, and clinical groups.
Re: Wuhan Coronavirus Resource Thread
I know some have said that post vaccination, some patients developed covid disease. This is true. After 1 dose the patient can still have the disease if within 14 days when there is no time for protective antibodies to develop. After 2nd dose it diminishes considerably. Also one needs to understand that certain groups of people dont mount enough protective immune response due to their unique characteristics like age diseases cancer etc etc.
many studies done in usa uk europe and India suggest that vaccines prevent almost 100%(not 100 %) severe diseases , and very effcetive in majority of patients.
In April 2021 MOHW website mentions study done that both covaxin and covishield have 0.004 and 0.003% cases after the respective doses. this is for bioth 1 and 2nd doses. This is similar to stats from pfizer and astra zeneca etc elsewhere
many studies done in usa uk europe and India suggest that vaccines prevent almost 100%(not 100 %) severe diseases , and very effcetive in majority of patients.
In April 2021 MOHW website mentions study done that both covaxin and covishield have 0.004 and 0.003% cases after the respective doses. this is for bioth 1 and 2nd doses. This is similar to stats from pfizer and astra zeneca etc elsewhere
Re: Wuhan Coronavirus Resource Thread
Thanks, this is the sort of information the original post should have contained. If someone just says 'people are dying despite vaccination', then you are feeding vaccine hesitancy. It's important for clear data on these cases to be available, because a lot of hesitancy is driven by unbacked anecdotes on WhatsApp. How you present the information makes a huge difference to whether the information constitutes actionable data, or whether its simply more scaremongering on SM.Thakur_B wrote:Suraj ji, most of the test centres are not feeding vaccination status in RTPCR test data, which has led to data being incomplete.
Be rest assured I am not feeding "heard it from someone cases". Here is a summary of cases in family and friends.
Case 1 - Neighbour, Male 75, comorbidities - Coronary Heart Disease - Vaccine status both shots of Covishield with 4 week gap - Infection after 2 weeks of second dose - deceased
Case 2 - Doctor, Male around 50, Comorbidities - None, Vaccine status - both doses of covishield, infection about a month after second dose - deceased
Case 3 - both of my Parents, Age 67/70, Comorbidities - father has mild Asthma, vaccine status - both doses of covishield with 4 week interval - infection two weeks after second dose - recovered without any issues.
Case 4 - FIL, Age 73, Comorbidities - Mild hypertension, vaccine status - single dose of covishield, Infection - 3 weeks after first dose - recovered with oxygen support
Case 5 - Cousin, Age 55, comorbidities - none, vaccine status, single dose of covishield, infection - 4 weeks after first dose - recovered after oxygen and ventilator support.
Case 6 - Colleagues mother, Age 77, comorbidities - coronary heart diseases, infection - 5 weeks after first dose, required oxygen and ventilator support - deceased.
So yes Suraj ji, break through cases are not rare. Hospitalisation after vaccination is also not rare. These are just cases in immediate friends and family.
Also, it is my request to not treat this kind of information as anti-vaxx propaganda or FUD. Probably all these cases of break through were indeed rare, but till data gets consolidated, we should be vary.
Re: Wuhan Coronavirus Resource Thread
Very hopeful news. Interesting solution to a problem which is personally delightful as the scientist is someone I know (IIT PhD). From Dr. Harsvardhan:
There are stories in news media.Simply phenomenal! - researchers at IIT HYDERABAD have developed oral tablets of #AmphotericinB to treat post #COVID19 fungal infections.
Funded by Department of Science and Technology, Government of India's Nanomission, the team has kept tech free of IP rights to enable quick mass production of the drug, once approved.
Re: Wuhan Coronavirus Resource Thread
The numbers I have seen from reliable sources where good data exist - Among the HCW/FLW where about 67% of the group members were fully vaccinated and about 33% were not (I was surprised to see such a high number - did not know vaccine hesitancy existed that much in this group) - about 97% of the deaths came from unvaccinated group. Iow 1/3 of the group which was vaccinated contributed to all but 3% of the deaths.
The serious illness / Hospitalization / Deaths etc numbers are not negligible in India - primary some think due to variants / loss of immunity / vaccine efficacy etc BUT still the numbers, thankfully, are *very* good.
1% of 100,000 cases is about 1000 a large number but it 99,000 lives are still quite good.
****
Here is projection of deaths (again source is Sutra Model)
(Seems it has peaked, but blue curve is still hovering. Likely due to the fact that past deaths are being recorded only now. By the time second wave subsides this number could be 380,000 ...
---
BTW , NYT article (written by Bagdad Bureau chief) was trash - It just multiplied arbitrary numbers to produce millions of deaths etc..
The serious illness / Hospitalization / Deaths etc numbers are not negligible in India - primary some think due to variants / loss of immunity / vaccine efficacy etc BUT still the numbers, thankfully, are *very* good.
1% of 100,000 cases is about 1000 a large number but it 99,000 lives are still quite good.
****
Here is projection of deaths (again source is Sutra Model)
(Seems it has peaked, but blue curve is still hovering. Likely due to the fact that past deaths are being recorded only now. By the time second wave subsides this number could be 380,000 ...
---
BTW , NYT article (written by Bagdad Bureau chief) was trash - It just multiplied arbitrary numbers to produce millions of deaths etc..
Re: Wuhan Coronavirus Resource Thread
Today's official vaccination numbers from PIB:
COVID-19 Vaccination Update- Day 136
Cumulative Day 136 (21.58cr) - Day 134 (21.18cr) = 40 lakh doses total over Sunday and Monday.
COVID-19 Vaccination Update- Day 136
Since there were no PIB numbers reported yesterday (Sunday), I am applying Suraj San's formulate the total difference for two days from last reported numbers on Saturday:Cumulative Vaccine Coverage exceeds 21.58 Crore
More than 2.02 Cr beneficiaries of age group 18-44 Vaccinated so far
More than 25 lakh Vaccine Doses administered today till 7 pm
The cumulative number of COVID-19 vaccine doses administered in the country exceeded 21.58 Cr (21,58,18,547) as per the 7 pm provisional report today.
12,23,596 beneficiaries of the age group 18-44 years received their first dose and 13,402 beneficiaries of the same age group received their second dose of COVID vaccine today. Cumulatively, 2,02,10,889 persons across 37 States/UTs have received their first dose and total 23,491 have received their second dose since the start of Phase-3 of the vaccination drive. Bihar, Delhi, Gujarat, Haryana, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Tamil Nadu, Uttar Pradesh and West Bengal have administered more than 10 lakh beneficiaries of the age group 18-44 years for the first dose of COVID vaccine.
The total of 21,58,18,547 include 98,83,778 Healthcare Workers (HCWs) who have taken the 1st dose and 67,87,633 HCWs who have taken the 2nd dose, 1,56,67,311 Frontline Workers (FLWs) (1st dose), 85,21,965 FLWs (2nd dose), 2,02,10,889 for 18-44 years of age group (1st dose) and 23,491 for 18-44 years of age group (2nd dose). 6,64,02,012 for over 45 years old to 60 years old (1st Dose), 1,07,15,693 for over 45 years old to 60 years old (2nd dose), 5,88,31,736 for above 60 years (1st Dose) and 1,87,74,039 for above 60 years (2nd Dose).
As on Day-136 of the vaccination drive (31st May, 2021), total 25,52,501 vaccine doses were given. 22,75,324 beneficiaries were vaccinated for 1st dose and 2,77,177 beneficiaries received 2nd dose of vaccine as per the provisional report till 7 P.M.
Cumulative Day 136 (21.58cr) - Day 134 (21.18cr) = 40 lakh doses total over Sunday and Monday.
Re: Wuhan Coronavirus Resource Thread
Close to commit over $1-bn to Moderna for COVID-19 booster vaccine; Provide price capping waiver, indemnity: Cipla to Govt
Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty, while stating that it is close to committing over USD 1-billion as advance to the US major, sources said on Monday.
Requesting the government to provide confirmation on four critical points --- exemption from price restriction, indemnification, bridging trial waiver and basic customs duty exemption, Cipla has said such an assurance will help make this significant financial commitment of more than USD 1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India, sources privy to the development said.
Cipla's latest communication to the government, dated May 29, follows a high-level meeting held recently during which it was discussed that Moderna has proposed to launch a single-dose vaccine for the Indian market, for which, they were in discussion with Cipla and other Indian companies.
It was also discussed in that meeting that orders for supply of the vaccine in 2022 may be placed with Moderna expeditiously and that Cipla has evinced interest to procure 50 million doses from Moderna for 2022.
Seeking exemption from price restriction, Cipla said, "Given the size of the population we need to immunize with boosters, it is our avid belief that the government and private players can work together to deliver the vaccination programme, best serving the public interest."
"Any restriction brought on pricing may dissuade the mRNA players from providing their vaccines in India, considering the serious competing demand by other countries chasing the limited supply of vaccines," a source quoted Cipla as having communicated to the Indian government.
The company has further requested for the government's assurance that no price capping would apply for imported vaccines to be provided through private hospitals and that the booster vaccine can be covered under the liberalised pricing policy and kept exempt from any price capping.
Re: Wuhan Coronavirus Resource Thread
Saturday - 3MKakkaji wrote:Today's official vaccination numbers from PIB:
COVID-19 Vaccination Update- Day 136
Since there were no PIB numbers reported yesterday (Sunday), I am applying Suraj San's formulate the total difference for two days from last reported numbers on Saturday:Cumulative Vaccine Coverage exceeds 21.58 Crore
More than 2.02 Cr beneficiaries of age group 18-44 Vaccinated so far
More than 25 lakh Vaccine Doses administered today till 7 pm
The cumulative number of COVID-19 vaccine doses administered in the country exceeded 21.58 Cr (21,58,18,547) as per the 7 pm provisional report today.
12,23,596 beneficiaries of the age group 18-44 years received their first dose and 13,402 beneficiaries of the same age group received their second dose of COVID vaccine today. Cumulatively, 2,02,10,889 persons across 37 States/UTs have received their first dose and total 23,491 have received their second dose since the start of Phase-3 of the vaccination drive. Bihar, Delhi, Gujarat, Haryana, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Tamil Nadu, Uttar Pradesh and West Bengal have administered more than 10 lakh beneficiaries of the age group 18-44 years for the first dose of COVID vaccine.
The total of 21,58,18,547 include 98,83,778 Healthcare Workers (HCWs) who have taken the 1st dose and 67,87,633 HCWs who have taken the 2nd dose, 1,56,67,311 Frontline Workers (FLWs) (1st dose), 85,21,965 FLWs (2nd dose), 2,02,10,889 for 18-44 years of age group (1st dose) and 23,491 for 18-44 years of age group (2nd dose). 6,64,02,012 for over 45 years old to 60 years old (1st Dose), 1,07,15,693 for over 45 years old to 60 years old (2nd dose), 5,88,31,736 for above 60 years (1st Dose) and 1,87,74,039 for above 60 years (2nd Dose).
As on Day-136 of the vaccination drive (31st May, 2021), total 25,52,501 vaccine doses were given. 22,75,324 beneficiaries were vaccinated for 1st dose and 2,77,177 beneficiaries received 2nd dose of vaccine as per the provisional report till 7 P.M.
Cumulative Day 136 (21.58cr) - Day 134 (21.18cr) = 40 lakh doses total over Sunday and Monday.
Sunday - 1 M from https://dashboard.cowin.gov.in/
Re: Wuhan Coronavirus Resource Thread
^^^Seven day average is going up..(And it is going higher in next few weeks if trouble makers don't make trouble)
Also
(Not total number of shots ... many have received 2 shots)
BTW India's scientists and admin people are quite confident now that by the end of this year - India will have more than enough shots for *everyone* who wants to get a vaccine - we will have shots and infrastructure to deliver it..The intensity of the second wave did caught us a little unprepared with shortage of O2 and beds etc.. will not happen again as we have learned a lot.
Also
(Not total number of shots ... many have received 2 shots)
BTW India's scientists and admin people are quite confident now that by the end of this year - India will have more than enough shots for *everyone* who wants to get a vaccine - we will have shots and infrastructure to deliver it..The intensity of the second wave did caught us a little unprepared with shortage of O2 and beds etc.. will not happen again as we have learned a lot.
Last edited by Amber G. on 01 Jun 2021 03:43, edited 1 time in total.
Re: Wuhan Coronavirus Resource Thread
Prof Ashutosh Sharma (Secretary DST) interviewed by Purnima Sharma : What one can do to protect themselves from this Virus. Nice interview in Hinidi : "आम लोग इस वायरस के संक्रमण को रोकने के लिए क्या कर सकते हैं ?"
Re: Wuhan Coronavirus Resource Thread
Delhi’s IGI Airport launches dedicated COVID-19 vaccine centre at Terminal-1; details here
This is what Phase 3 liberalisation was designed to do. That the workers critical to keep the economy going, can get their jabs quickly through their employers. It is picking up momentum now.Delhi Airport: Today, Delhi’s Indira Gandhi International Airport announced the launch of a dedicated vaccination centre for COVID-19 in association with Manipal Hospital, starting from 1 June 2021. The facility set up at Terminal-1 (T-1) of IGI Airport, aims to provide vaccination opportunity to over 60,000 employees of various stakeholders- airlines, ground handling agencies, Air Traffic Control, cargo business, among others, working at the international airport, Delhi International Airport Limited (DIAL) said. All airport employees who are over 18 years of age can register themselves and get jabbed at the vaccination centre on a payment basis, either directly by themselves or through their employer, according to a PTI report.
Re: Wuhan Coronavirus Resource Thread
Yes. However, an alternative model would have been to gradually expand the definition of "frontline worker" to cover more employees. The differential cost between private hospitals versus state and central governments seems more a way to either control cost for government or accommodate a population set that expects differential treatment at higher cost.
Re: Wuhan Coronavirus Resource Thread
No use. Test centres do not feed vaccination status. Death certificates do not mention covid, rather ARDS, Cardiac Arrest, Multiple Organ Failure etc. More than a dozen people have died at my workplace due to covid. None had their cause of death listed as Covid. Listing the cause of death as covid opens up possibility of compensating the families as Covid has been notified as a disaster. Insurance companies are chickening out in accounting them as workplace related incident. We are an essential service provider, so working from home was not an option for employees. Our organisation had to resort to making an employee fund to compensate the families of the deceased.Pratyush wrote:The thing with vaccination is that the data is collected using adhar. Therefore, in case of breakthrough infection it will be relatively easy to arrive at the details of the cases relatively easily.
Re: Wuhan Coronavirus Resource Thread
Tamil Nadu has only 2 days of stock for Covid-19 Vaccines
Finally, TN had finally picked up on the vaccination and the earlier stocks are drying out and awaiting fresh supplies.Express News Service
CHENNAI: Tamil Nadu Health Minister Ma Subramanian on Monday said that the state’s COVID-19 vaccine stock will be exhausted in the next two days and it is awaiting more supplies from the central government.
Addressing reporters after inaugurating the second batch of 504 oxygen beds here at the Chennai Trade Centre, Health Minister Ma Subramanian said that the state has five lakh doses of COVID-19 vaccines, which would be exhausted in two days. “We are awaiting the Centre's supply of fresh doses and we hope they will send it soon. Once we get it, we will supply it to all the districts,” the minister said.
The minister said that the central government has given a total of 83 lakh doses and the Tamil Nadu government has procured an additional 13 lakh doses through its orders. “We totally have got 96 lakh doses. We have placed orders worth Rs 85.48 lakh for 25 lakh doses. We have received 13 lakh doses and another 12 lakh are expected to come soon,” the minister added.
ALSO READ: All Chennai Corporation zones see decline in Covid-19 cases
He also said that global tenders for 3.5 crore vaccine doses would be opened on June 5 and the successful bidders will be giving vaccines within six months of bidding. “We have also requested the Centre to either use the Chengalpet vaccination manufacturing plant or hand it over to the state to produce the vaccine. Our MPs in Delhi are directly in talks with central MPs and a decision in this regard is expected soon,” the minister said.
He also responded to the criticism by former Chief Minister Edappadi K Palaniswami who had said that the government was hiding the death numbers. “We have told all district officials not to hide any deaths during our visits to the districts. The Tamil Nadu government has no need to hide any deaths,” he said.
Meanwhile, 203 patients are undergoing treatment for COVID-19 at the Chennai Trade Centre where an additional 504 beds have been added. The Centre now totally has 864 beds, of which 804 are oxygen beds. “Even though COVID-19 is decreasing, the Chief Minister has given instructions to increase the beds,” the minister added.
On Monday, the minister also inaugurated a 120-bed COVID-19 facility which will offer treatment through the practices of yoga and naturopathy.
Re: Wuhan Coronavirus Resource Thread
You and I are talking about different things. I am talking about breakthrough infections and you are talking about deaths.Thakur_B wrote:
No use. Test centres do not feed vaccination status. Death certificates do not mention covid, rather ARDS, Cardiac Arrest, Multiple Organ Failure etc. More than a dozen people have died at my workplace due to covid. None had their cause of death listed as Covid. Listing the cause of death as covid opens up possibility of compensating the families as Covid has been notified as a disaster. Insurance companies are chickening out in accounting them as workplace related incident. We are an essential service provider, so working from home was not an option for employees. Our organisation had to resort to making an employee fund to compensate the families of the deceased.
My point is that during vaccination adhar details are collected.
In case of sickness or even when testing is being done. The test is conducted using adhar as a common ID. So the details of breakthrough infections can easily arrived at.
Re: Wuhan Coronavirus Resource Thread
As on Day-137 of the vaccination drive (1st June, 2021), total 22,08,941 vaccine doses were given. 19,45,581 beneficiaries were vaccinated for 1st dose and 2,63,360 beneficiaries received 2nd dose of vaccine as per the provisional report till 7 P.M.
The cumulative number of COVID-19 vaccine doses administered in the country exceeded 21.83 Cr (21,83,58,591) as per the 7 pm provisional report today.
Cumulative Day 137 (21.83) - Day 136 (21.58cr) = 25 lakh doses. (morning update pending)
The cumulative number of COVID-19 vaccine doses administered in the country exceeded 21.83 Cr (21,83,58,591) as per the 7 pm provisional report today.
Cumulative Day 137 (21.83) - Day 136 (21.58cr) = 25 lakh doses. (morning update pending)
Re: Wuhan Coronavirus Resource Thread
This is an excellent interview - please do watch.
Prof Vidyasagar (author of Sutra Model) goes over many things I have been talking - in a easy to understand presentation.
(Someone can summarize this - but it is only a 10 minutes video - worth watching)
https://youtu.be/zmfzIAt2jGU
*** Meanwhile: Big news for the website http://sutra-india.in. - The automated updater is now working so all plots are up-to-date and will remain so in future .. more districts are coming online. If there is a big discrepancy between *actual* and projected value in your district (and you have reliable data) , please put a note here (or send a note to the prof) in the forum so the parameters can be further refined,
Prof Vidyasagar (author of Sutra Model) goes over many things I have been talking - in a easy to understand presentation.
(Someone can summarize this - but it is only a 10 minutes video - worth watching)
https://youtu.be/zmfzIAt2jGU
*** Meanwhile: Big news for the website http://sutra-india.in. - The automated updater is now working so all plots are up-to-date and will remain so in future .. more districts are coming online. If there is a big discrepancy between *actual* and projected value in your district (and you have reliable data) , please put a note here (or send a note to the prof) in the forum so the parameters can be further refined,
Re: Wuhan Coronavirus Resource Thread
https://www.rediff.com/news/report/no-m ... 210601.htm
Rediff.com » News » No mixing of Covid vaccines or single-shot dose: Centre
Source: PTI - Edited By: hem, June 01, 2021
The government on Tuesday said mixing of COVID-19 vaccines is not the protocol yet and there is no change in the schedule of two-dose vaccines Covishield and Covaxin, amid reports that India is planning to start trials to test the feasibility of a regimen that uses two different jabs and the effectiveness of a single dose.
It said the standard operating procedure of administering the doses of the same vaccine should be followed.
Some media reports have claimed that India may begin trials "in a few weeks" to see if mixing two different COVID-19 vaccines can help boost the immune response to the virus. Addressing a press conference, NITI Aayog (Health) member Dr V K Paul presented two scenarios on the mixing of Covid vaccines. "On the one hand, it might be possible that mixing of vaccines can lead to bad reactions... On the other, science also indicates that mixing of vaccines could be useful and lead to an increase in immunity but a severe reaction and harm cannot be ruled out and therefore there is research going on in other countries."This is a scientific matter and till the time it does not get sorted, we will say it is an unresolved scientific question over which there is no change in our programme," he said.
.....
Gautam
Rediff.com » News » No mixing of Covid vaccines or single-shot dose: Centre
Source: PTI - Edited By: hem, June 01, 2021
The government on Tuesday said mixing of COVID-19 vaccines is not the protocol yet and there is no change in the schedule of two-dose vaccines Covishield and Covaxin, amid reports that India is planning to start trials to test the feasibility of a regimen that uses two different jabs and the effectiveness of a single dose.
It said the standard operating procedure of administering the doses of the same vaccine should be followed.
Some media reports have claimed that India may begin trials "in a few weeks" to see if mixing two different COVID-19 vaccines can help boost the immune response to the virus. Addressing a press conference, NITI Aayog (Health) member Dr V K Paul presented two scenarios on the mixing of Covid vaccines. "On the one hand, it might be possible that mixing of vaccines can lead to bad reactions... On the other, science also indicates that mixing of vaccines could be useful and lead to an increase in immunity but a severe reaction and harm cannot be ruled out and therefore there is research going on in other countries."This is a scientific matter and till the time it does not get sorted, we will say it is an unresolved scientific question over which there is no change in our programme," he said.
.....
Gautam
Re: Wuhan Coronavirus Resource Thread
Excuse me if this has been posted before
Malaysia now has more Covid cases per million than India
https://www.cnbc.com/2021/05/26/covid-m ... lainternal
Malaysia now has more Covid cases per million than India
https://www.cnbc.com/2021/05/26/covid-m ... lainternal
Re: Wuhan Coronavirus Resource Thread
^^^ So does Denmark, New Zealand, UAE, UK, Baharin, Honk Kong, Israel, USA, Most of Europe etc.,,(have more covid patients per million)
(Second wave in India was very bad and thus the situation is rather bad)
Official counts of many Asian countries (us eg Nepal, South Korea ) etc are better than India--
I think we (our scientists and people in India) learned from this bad second wave and all indications are the third wave (if it occurs) will be very mild.. The Delta variant which is similar or even more transmissive (about 1.6-2 x) than notorious P1 (Gamma - Brazil) and lack of mask wearing in India caused this tremendous spread.
(Second wave in India was very bad and thus the situation is rather bad)
Official counts of many Asian countries (us eg Nepal, South Korea ) etc are better than India--
I think we (our scientists and people in India) learned from this bad second wave and all indications are the third wave (if it occurs) will be very mild.. The Delta variant which is similar or even more transmissive (about 1.6-2 x) than notorious P1 (Gamma - Brazil) and lack of mask wearing in India caused this tremendous spread.
Re: Wuhan Coronavirus Resource Thread
@Amber G:
The cvoter pollster Yashwant Deshmukh claims based on his surveys (asking people whether they lost a family member etc) that 1.8 million people lost their lives in India due to covid so far. This number seems absurd to me. Even with any potential undercounting, I would not expect the real toll to be more than 2-3 times the official figure. How reliable would you expect YD's method to be ? It could be also that he has an anti-Modi bias given that he is seeks approval in liberal circles in spite of his family having a sangh background.
The cvoter pollster Yashwant Deshmukh claims based on his surveys (asking people whether they lost a family member etc) that 1.8 million people lost their lives in India due to covid so far. This number seems absurd to me. Even with any potential undercounting, I would not expect the real toll to be more than 2-3 times the official figure. How reliable would you expect YD's method to be ? It could be also that he has an anti-Modi bias given that he is seeks approval in liberal circles in spite of his family having a sangh background.
Re: Wuhan Coronavirus Resource Thread
It is possible. But I do not believe deaths themselves are undercounted. But deaths due to COVID19 may be under counted by a factor of two. With a crude death rate 7.1 per 1000 India has around 10 million deaths in a year or 28 k per day. We are seeing 4000 deaths per day for the past few days 15% increase than the normal. If the deaths are many times this number it will be easily noticeable. We may know actual number of deaths that happened in 2020 next year.
Re: Wuhan Coronavirus Resource Thread
1.8 Million sounds plausible - i am hearing too many deaths from social circles in chennai. multiple in the same family. the worst case is to look at the overall death rate and calculate the worst case by giving it a % due to covid - what if 80% is due to covid? other causes due to infection/accident etc are way low now...
Re: Wuhan Coronavirus Resource Thread
Please avoid throwing anecdotes around. The topic is controversial as it is, and anecdotes offer no actionable information. Here's an example of an evidence-based analysis of the topic:
An Evidence-Based Estimation Of Covid Deaths That Is Far Better Than NYT’s
An Evidence-Based Estimation Of Covid Deaths That Is Far Better Than NYT’s
Re: Wuhan Coronavirus Resource Thread
I may put something in more details later (or link a good technical analysis) but the best description - accurate description I found from someone whose job is to know such data and who I *never* heard using strong languages said this "trash peddled in NYT article"
Meanwhile please see this is quite nicely done:
and this https://threadreaderapp.com/thread/1397 ... 67205.html
and this https://threadreaderapp.com/thread/1397 ... 86944.html
Meanwhile please see this is quite nicely done:
https://twitter.com/Uncommo52204052/sta ... 49632?s=20Debunking claims of 5-10x deaths:
Only during spike-phase, when system lost control, does this absurd claim even need debunking. Even then, it's an extraordinary claim requiring extraordinary evidence. I'll show that evidence presented is far from extraordinary.
In such studies, 'analysts' just throw out absolute numbers (40k excess deaths here, 11k there). To make it meaningful, I calculate excess deaths per month per million population. We can compare across regions/times. We can compare to India's all-cause mortality of 600/month/mn...
and this https://threadreaderapp.com/thread/1397 ... 67205.html
and this https://threadreaderapp.com/thread/1397 ... 86944.html
Re: Wuhan Coronavirus Resource Thread
One crore vaccination per day by mid-July
The country will be able to vaccinate more than a crore people per day by early to mid July and the entire country will be covered by December, Dr Balram Bhargava, DG, Indian Council of Medical Research, said on Tuesday.
The country is still in the midst of a ferocious second wave of the Covid pandemic and although it is abating because of the containment and testing, the country cannot return to business as usual, Bhargava warned. For opening up a district, test positivity has to be less than 5%, vaccination of 70% of those above 60 years and those above 45 years with comorbidities should be vaccinated, and Covid-appropriate behaviour continues at all levels, Bhargava said.
Unlocking has to done patiently guided by the amount of vaccination that has been done for the vulnerable group, he said. The virus has been just suppressed but it can resurface anytime, he said. Care would have to be taken till such time that 70% of the vulnerable population has been vaccinated or herd immunity is achieved, Bhargava said.
Re: Wuhan Coronavirus Resource Thread
Biological E ties up with Canadian firm Providence for mRNA Covid vaccine
Hyderabad-based Biological E tied up with Calgary-based Providence Therapeutics to manufacture its mRNA technology-based Covid-19 vaccine and do clinical trials in India. The deal assumes significance as this gives India access to the mRNA technology.
The vaccine, named PTX-COVID19-B, is under development in Canada at the moment. Providence announced data from the phase 1 trials in May and will begin the phase 2 trials soon.
“The mRNA platform has emerged as the front runner in delivering the first vaccines for emergency use to combat the COVID-19 pandemic. Biological E. is very pleased to be able to work with Providence on its promising mRNA vaccine candidate. We hope to provide India and other countries yet another option to ramp up their efforts towards achieving herd immunity against COVID-19,” said Mahima Datla, Managing Director of Biological E Limited.
Providence will sell up to 30 mn doses of its mRNA vaccine to Biological E. It would also provide the necessary technology transfer to make the vaccine in India, with a minimum production capacity of 600 mn doses in 2022 and targets capacity of 1 bn doses.
“Biological E will be responsible for all clinical development and regulatory activities for the mRNA vaccine in India and other jurisdictions licensed by Biological E,” the company said.
India already has one mRNA vaccine in development by Pune-based Gennova Biopharmaceuticals which is in phase 1 clinical trials.
Apart from the J&J and Providence Covid-19 vaccine deals, Biological E also has under development a third candidate with Baylor College of Medicine. The Baylor College of Medicine – Biological E vaccine is set to begin phase 3 clinical trials in June. This is a protein sub-unit technology based vaccine, a technology that Biological E already had. This technology is used to make Hepatitis B vaccines.
The Indian government has indicated that in the second half of the year, it expects to receive 300 mn doses of the Biological E vaccine.
India is already in talks with US players Pfizer and Moderna for bringing their USFDA-approved mRNA Covid-19 vaccines to India.
Re: Wuhan Coronavirus Resource Thread
[url=https://www.business-standard.com/artic ... 423_1.html]
The World Health Organization (WHO) said on Tuesday it has approved a COVID-19 vaccine made by drugmaker Sinovac Biotech for emergency use listing, paving the way for a second Chinese shot to be used in poor countries.
A WHO emergency listing is a signal to national regulators on a product's safety and efficacy. It will also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which faces major supply problems due to an Indian export suspension.
The independent panel of experts said in a statement it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later. There was no upper age limit as data suggested it is likely to have a protective effect in older people.
Sinovac said that it had supplied more than 600 million doses of its vaccine at home and abroad as of end-May and over 430 million doses have been administered.
Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51% of those vaccinated and prevented severe COVID-19 and hospitalisation in 100% of the studied population, the WHO said.
The WHO's separate Strategic Advisory Group of Experts (SAGE) had said previously in a review document that vaccine efficacy in multi-country Phase III clinical trials ranged from 51% to 84%.
Indonesia's health ministry said on May 12 that its study of 120,000 healthcare workers who had received the vaccine found it was 94% effective at preventing symptomatic disease.
In a preliminary evaluation, the SAGE panel found that the shot was efficacious in preventing COVID-19 in adults under 60, but that some quality data on the risk of serious adverse effects was lacking.
It cited evidence gaps in safety in pregnancy, and on safety and clinical protection in older adults, those with underlying disease, and evaluation of rare adverse events detected through post-authorization safety monitoring.
The SAGE experts, who issue policy recommendations to states and dosage guidelines, reviewed Sinovac clinical data last month.
Re: Wuhan Coronavirus Resource Thread
Eagerly waiting for update on Zydus. Based on the last communication, there should be news by middle of this month.
Re: Wuhan Coronavirus Resource Thread
Got my son vaccinated today (18+ category). This time it is much faster. 2 minutes, no waiting before or after. No stupid bureaucracy (unlike when I got vaccinated myself in April). Hope they take this approach for all (not just 18+). I know there are a few cases of people collapsing immediately after vaccination, so a good trade-off is to make the waiting optional.
Re: Wuhan Coronavirus Resource Thread
2500 Doses of #CovidVaccine found wasted in 500 vials thrown Away in Just 35 Vaccination Centres Investigated by Bhaskar team in 8 Districts of Congress Ruled Rajasthan
11.5 lakh COVID-19 vaccine doses wasted in Rajasthan, BJP leader slams Congress for the criminal act: Read details
11.5 lakh COVID-19 vaccine doses wasted in Rajasthan, BJP leader slams Congress for the criminal act: Read details
22 May, 2021
OpIndia Staff
The wastage rate recorded in Rajasthan's Churu district stood the highest at 39.7 per cent, according to reports.
In Rajasthan 11.5 lakh doses of Covid-19 vaccine wasted
Rajasthan reported the highest percentage of Covid-19 vaccine wastage. According to a report by Hindi daily Patrika, a total of 11.5 lakh doses of Covid-19 vaccine, which amounts to almost 7 per cent, has been wasted in the Congress-ruled state.
Though many districts in Rajasthan have reportedly wasted several doses of vaccines, the wastage rate recorded in Rajasthan’s Churu district stood the highest at 39.7 per cent, followed by Hanumangarh, where the waste per cent was recorded to be 24.60 per cent. Bharatpur stood at number three after it reported 17.13 per cent. Kota finished fourth with a 16.71 per cent of waste rate.
Congress runs a sinister anti-vaccine campaign
For the past few months, non-NDA parties, especially Congress and AAP have been playing petty politics over the Central government’s vaccination drive.
Congress, which has been persistently trying to milk the Covid-19 crisis to tarnish the image of the BJP government, has been running a sinister campaign against Indian vaccine makers while campaigning for much more costly vaccines made by foreign companies. One of the strategies employed by them was discrediting the indigenous Covaxin vaccine, developed by Bharat Biotech. The government had approved its emergency use in the month of January.
Using this as the primary tool for propaganda, Congress leaders such as Shashi Tharoor, Manish Tewari, and Chhattisgarh health Minister TS Singh Deo trivialised the vaccination drive altogether. And, obviously, in all this, the leftist media has stood shoulder to shoulder with the Congress party, helping in accentuating the panic and vaccine hesitancy among people.
Re: Wuhan Coronavirus Resource Thread
Hard to understand that article.Suraj wrote:Please avoid throwing anecdotes around. The topic is controversial as it is, and anecdotes offer no actionable information. Here's an example of an evidence-based analysis of the topic:
An Evidence-Based Estimation Of Covid Deaths That Is Far Better Than NYT’s
Re: Wuhan Coronavirus Resource Thread
More than 22 lakh Vaccine Doses administered today till 7 pm
The cumulative number of COVID-19 vaccine doses administered in the country exceeded 22.08 Cr (22,08,62,449) as per the 7 pm provisional report today.
Cumulative Day 138 (22.08) - Day 137 (21.83cr) = 25 lakh doses. (morning update pending)[/quote]
The cumulative number of COVID-19 vaccine doses administered in the country exceeded 22.08 Cr (22,08,62,449) as per the 7 pm provisional report today.
Cumulative Day 138 (22.08) - Day 137 (21.83cr) = 25 lakh doses. (morning update pending)[/quote]